about
Antiangiogenic mechanisms and factors in breast cancer treatmentTowards Dynamic Contrast Specific Ultrasound Tomography.Deep tissue photoacoustic computed tomography with a fast and compact laser system.Biomedical photoacoustics: fundamentals, instrumentation and perspectives on nanomedicine.A brief account of nanoparticle contrast agents for photoacoustic imaging.A Green Synthesis of Carbon Nanoparticle from Honey for Real-Time Photoacoustic ImagingMolecular photoacoustic tomography with colloidal nanobeacons.Single-walled carbon nanotubes as a multimodal-thermoacoustic and photoacoustic-contrast agentThe effect of exercise training on the level of tissue IL-6 and vascular endothelial growth factor in breast cancer bearing miceAbalone visceral extract inhibit tumor growth and metastasis by modulating Cox-2 levels and CD8+ T cell activity.Vasohibin 2 as a potential predictor of aggressive behavior of triple-negative breast cancer.In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts.Antibodies and Tyrosine Kinase Inhibitors in Breast Cancer Therapies.Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.Targeted Therapy: Can It Substitute for Chemotherapy?Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer.Exploring novel KDR inhibitors based on pharmaco-informatics methodology.Triple-negative breast cancer: new perspectives for targeted therapies.Anti-angiogenic peptides for cancer therapeuticsUnfolded protein response is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin.URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast CancerChanges in Cytokines of the Bone Microenvironment during Breast Cancer Metastasis.Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2.Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatmentThe expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancerTargeting angiogenesis in metastatic breast cancerThalidomide and irradiation combination therapy increases substance P levels in vitroGermline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.Antiangiogenic therapies in early-stage breast cancer.Calibration and optimization of 3D digital breast tomosynthesis guided near infrared spectral tomography.ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.Breast tumour angiogenesisIncreased Umbilical Cord PAI-1 Levels in Placental Insufficiency Are Associated with Fetal Hypoxia and Angiogenesis.Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor.The promise of dynamic contrast-enhanced imaging in radiation therapyAntiangiogenic agents in breast cancer.Neoadjuvant therapy in operable breast cancer: application to triple negative breast cancer.Leptin's Pro-Angiogenic Signature in Breast CancerBiologic therapies for advanced pancreatic cancer.
P2860
Q26751226-D31359FC-4FA1-49F4-A921-D4EA4EBE2993Q28597984-1B17DA80-7487-466A-8FF4-4994DCCA37C1Q30365501-EB81DAD5-3956-4278-9CA8-326F76D37078Q30366179-578C2959-0620-4B9A-B73C-963337587BD1Q30427324-591E5061-69B7-40D5-B006-3700CEAC17B1Q30453076-4C2F45DA-309D-4044-8F96-6466451B5F15Q30481075-EC59A5CD-9E21-4E1A-BF1D-1D6154D82DC1Q30487381-D6BD1D8B-7D5C-4009-B9D4-B35CBB517240Q33713934-21CEF0E3-BD69-42EB-BCEE-626BEC44BD48Q33723522-CAFF24C4-90E0-4F2C-B463-3B953752A2DEQ33850275-B60B3B7F-8EEC-43DA-92EC-544208BA8264Q34101555-0A06E113-F209-4DC2-8276-2801AAA2C8BFQ34140167-877AA7A4-3497-422C-A3E0-99AE7301D3C9Q34279214-190ECEBE-5E55-4ACD-8D4B-4138951B4838Q34284290-969D5F99-C8AC-4F2C-8E30-C8B94DF1BFF2Q34290867-748906FD-40C3-4809-B841-447E673EB990Q34600778-69D16E94-043C-448D-AF51-6AA3B3D7335EQ35001758-AA81B015-5312-4177-A14A-8D6123D209A0Q35043016-9F8D8E9D-346E-45AE-AE15-74709DDF7332Q35309992-3A2E9C69-EA0A-4EFE-9570-D5C8E8268B6AQ35623604-83523806-8D90-42BC-BABD-B30425CF78A4Q35684466-B62832D8-36A6-4166-A482-DFCDCE97182AQ35725996-4E6627D7-788D-4A84-886A-562DD9C6B9A5Q35838937-7886C5BD-4A0C-45F5-B9B4-C1F2E7192A66Q36020972-796D5C43-67F4-4334-83D9-DAC50F971935Q36181412-063BC7D2-17D0-4CF7-B2C3-AA593844B274Q36182795-7C576F46-DBB5-4C03-A8C5-B963A4C8AECAQ36230673-BF9E3635-A519-4352-AC5E-323504978C61Q36237852-A6C9E117-4CF2-491D-9F4C-1CF189551B40Q36318210-74AA7BF7-51B5-47D7-A7E8-ECB64C353CA7Q36372135-7056B091-1152-4DF0-BCCD-E1E042CF1B75Q36416481-371F0327-43F4-4615-A940-7ED2CA60F334Q36465291-0D246F0A-4FDF-40CC-86E8-54D769A70EAAQ36557018-A0BB132C-676E-4456-9B9E-AAB285EC232CQ36742307-E461990D-5BAD-4CC0-B31C-48F61DB99368Q36747134-9FAEC592-8E9D-4FB6-8AC3-440306B49C37Q37008618-39E54EB0-F4C3-4722-AFE4-7FC827F96402Q37105085-DE167CDB-A059-4B61-BBC7-36CE10307386Q37226530-FED04170-86F3-48BE-A65E-B40578CA3849Q37242685-2F3A2CD7-282D-4952-BF3F-3F1D5E8D8076
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Angiogenesis of breast cancer.
@ast
Angiogenesis of breast cancer.
@en
type
label
Angiogenesis of breast cancer.
@ast
Angiogenesis of breast cancer.
@en
prefLabel
Angiogenesis of breast cancer.
@ast
Angiogenesis of breast cancer.
@en
P356
P1476
Angiogenesis of breast cancer.
@en
P2093
Bryan P Schneider
Kathy D Miller
P304
P356
10.1200/JCO.2005.12.017
P407
P577
2005-03-01T00:00:00Z